Showing results (1-10 of 480) with videos related to
Sort By:
Pageof 48
Neurology|May 20, 1998
Levodopa therapy: consequences of the nonphysiologic replacement of dopamineT N ChaseDrugs|March 4, 1998
The significance of continuous dopaminergic stimulation in the treatment of Parkinson's diseaseT N ChaseClinical Pharmacology and Therapeutics|May 1, 1975
Fenfluramine in man: hypophagia associated with diminished serotonin turnoverI Shoulson, T N ChaseNeuropharmacology|June 1, 1995
Effects of SCH 32615, an enkephalinase inhibitor, on D-1 and D-2 dopamine receptor-mediated behaviorsC Marin, T N ChaseEuropean Journal of Pharmacology|February 9, 1993
Dopamine D1 receptor stimulation but not dopamine D2 receptor stimulation attenuates haloperidol-induced behavioral supersensitivity and receptor up-regulationC Marin, T N ChaseAmino Acids|October 10, 2002
Glutamate-mediated striatal dysregulation and the pathogenesis of motor response complications in Parkinson's diseaseJ D Oh, T N ChaseAnnals of Neurology|May 1, 1996
Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeysS M Papa, T N ChaseExperimental Neurology|March 1, 1997
Gene therapy for Parkinson's disease: an approach to the prevention or palliation of levodopa-associated motor complicationsM M Mouradian, T N ChasePageof 48